Phase II trial of concurrent erlotinib in locally advanced non-small cell lung cancer (LA-NSCLC)

被引：1
|
作者：
Hansen, O. [1 ]
Knap, M. [2 ]
Khalil, A. [2 ]
Nyhus, C. [3 ]
Brink, C. [4 ]
Hoffmann, L. [5 ]
Schytte, T. [1 ]
机构：
[1] Odense Univ Hosp, Oncol, Odense, Denmark
[2] Aarhus Univ Hosp, Oncol, Aarhus, Denmark
[3] Vejle Hosp, Oncol, Vejle, Denmark
[4] Odense Univ Hosp, Lab Radiat Phys, Odense, Denmark
[5] Aarhus Univ Hosp, Med Phys, Aarhus, Denmark
来源：
RADIOTHERAPY AND ONCOLOGY | 2017年 / 123卷
关键词：
D O I：
10.1016/S0167-8140(17)31664-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1229
引用
收藏
页码：S663 / S663
页数：1
相关论文
共 50 条
  • [1] A Phase II Trial of Primary Tumor SBRT Boost Prior to Concurrent Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
    Williams, T. M.
    Welliver, M. X.
    Brownstein, J. M.
    Otterson, G.
    Owen, D.
    Pan, J.
    Haglund, K. E.
    Shields, P. G.
    Bertino, E. M.
    Presley, C.
    He, K.
    Miller, E. D.
    Yang, X.
    Knopp, M.
    Essan, J. Kousou
    McElroy, S.
    Carbone, D. P.
    Bazan, J. G., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S90 - S90
  • [2] Concomitant radiotherapy (RT) with docetaxel for unresectable locally advanced non-small cell lung cancer (LA-NSCLC)
    Fuente, N.
    Mane, J. M.
    Rubio, I.
    Carrera, S.
    Martinez-Bueno, A.
    Lopez de Argumedo, G.
    Ferreiro, J.
    Abon, G.
    Garrido, P.
    Lopez-Vivanco, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] A randomized phase II trial of erlotinib or erlotinib and bevacizumab in patients with advanced EGFR mutant non-small cell lung cancer (NSCLC)
    Stinchcombe, T. E.
    Janne, P. A.
    Wang, X.
    Bertino, E. M.
    Weiss, J. M.
    Bazhenova, L.
    Gu, L.
    Lau, C. J.
    Paweletz, C. P.
    Jaslowski, A. J.
    Gerstner, G. J.
    Baggstrom, M. Q.
    Graziano, S. L.
    Beardenlii, J.
    Vokes, E. E.
    ANNALS OF ONCOLOGY, 2018, 29 : 522 - 522
  • [4] Concurrent chemoradiotherapy (cCTRT) for locally-advanced, unresectable non-small cell lung cancer (LA-NSCLC): A national survey of current practice
    Helbrow, J.
    Bayman, N.
    MacNicoll, F.
    Faivre-Finn, C.
    LUNG CANCER, 2012, 75 : S50 - S51
  • [5] Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
    Robinson, C. G.
    Contreras, J.
    DeWees, T. A.
    Jenkins, S.
    Waqar, S.
    Govindan, R.
    Baggstrom, M. Q.
    Morgensztern, D.
    Bottani, B. A.
    Przybysz, D., Jr.
    Roach, M. C., Jr.
    Bradley, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S17 - S17
  • [6] Lymphocyte-Sparing with Hypofractionated Proton Radiation in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
    Lin, A. J.
    Srivastava, A.
    Contreras, J.
    Campian, J. L.
    Badiyan, S. N.
    Roach, M. C., Jr.
    Bradley, J. D.
    Robinson, C. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E517 - E517
  • [7] A pilot study of a decision aid for patients with locally-advanced non-small cell lung cancer (LA-NSCLC)
    Brundage, MD
    Cosby, RH
    Feldman-Stewart, D
    Gregg, R
    Dixon, P
    Youssef, Y
    Mackillop, WJ
    MEDICAL DECISION MAKING, 1998, 18 (04) : 483 - 483
  • [8] Trimodality treatment using integrated chemoradiation with surgery for locally advanced, non-small cell lung cancer (LA-NSCLC)
    Karur, V.
    Lally, B.
    Scott, W.
    Goldberg, M.
    Millenson, M.
    Feigenberg, S.
    Mosvas, B.
    Mehra, R.
    Langer, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S460 - S460
  • [9] A phase II trial of concurrent radiochemotherapy with carboplatin (CBDCA) and weekly docetaxel (TXT) in locally advanced non-small cell lung cancer (NSCLC).
    Suzuki, R
    Taniguchi, H
    Kondoh, Y
    Shindoh, J
    Matsumoto, S
    Hiramatsu, T
    Gonda, H
    Baba, K
    Hasegawa, Y
    Shimokata, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 659S - 659S
  • [10] Randomized Phase II Trial of Metformin in Combination with Chemoradiotherapy (CRT) in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC); the OCOG-ALMERA trial (NCT02115464)
    Tsakiridis, T.
    Pond, G.
    Wright, J.
    Ellis, P.
    Abdulkarim, B. S.
    Ahmed, N.
    Robinson, A. G.
    Valdes, M.
    Okawara, G.
    Swaminath, A.
    Wierzbicki, M.
    Levine, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S104 - S104
12345